Astragaloside IV alleviates skin fibrosis by modulating fibroblast phenotype in keloids
European Journal of Dermatology · 2024
DOI: 10.1684/ejd.2024.4754 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Dermatology, 2024. Verfasst von Hu Gao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wound Repair & Rehabilitation Center, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan430000, China. Hauptthemen laut MEDLINE: Keloid, Triterpenes, Saponins, Fibroblasts. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wound Repair & Rehabilitation Center, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan430000, China.
- Department of Dermatology, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan430000, China.
Zitieren
APA
Gao, H., Sun, X., & Zhang, X. (2024). Astragaloside IV alleviates skin fibrosis by modulating fibroblast phenotype in keloids. European Journal of Dermatology. https://doi.org/10.1684/ejd.2024.4754
Vancouver
Gao H, Sun X, Zhang X. Astragaloside IV alleviates skin fibrosis by modulating fibroblast phenotype in keloids. European Journal of Dermatology. 2024. doi:10.1684/ejd.2024.4754
BibTeX
@article{Gao2024,
author = {Gao, Hu and Sun, Xian and Zhang, Xiangming},
title = {Astragaloside IV alleviates skin fibrosis by modulating fibroblast phenotype in keloids},
journal = {European Journal of Dermatology},
year = {2024},
doi = {10.1684/ejd.2024.4754}
}
EUVIMED